[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:psoriasis":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":228,"states":229},"Psoriasis",35,24,[8,16,23,29,35,41,48,54,60,66,72,78,84,90,96,102,108,114,120,126,132,138,144,150,156,163,169,175,181,189,195,202,208,215,221],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07321873","A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis",[12],"Phase 2","RECRUITING","2026-08-26T02:17:13.277148Z","2026-07-05T05:32:16.674848Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT04119102","Duobrii in Combination With Biologics",[20],"Phase 4","2026-08-26T02:18:15.214990Z","2026-05-05T02:43:29.384505Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT03392337","An Open-Label, Pilot Study to Evaluate the Efficacy of Narrowband Ultraviolet-B Phototherapy Three Times Weekly for Twelve Weeks in Moderate-to-Severe Psoriasis Patients",[],"2026-08-26T02:18:59.761994Z","2026-05-05T02:43:28.504763Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT05004727","Multi-Center PAMPA Study",[20],"2026-08-26T02:15:27.567165Z","2026-05-05T02:43:28.218784Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT06399432","Mediterranean Diet vs no Dietary Intervention for Improving Signs and Symptoms of Psoriasis in Patients Treated With Anti-IL-17 or Anti-IL-23 Inhibitors",[],"2026-08-26T02:16:54.044282Z","2026-05-05T02:43:28.134283Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":46,"content_modified":47},"NCT06846710","Evaluate the Safety and Pharmacokinetics\u002FPharmacodynamics of HS-20118",[45],"Phase 1","2026-08-26T02:19:08.084946Z","2026-05-05T02:43:27.828109Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT04372277","Taltz in Combination With Enstilar for Psoriasis",[20],"2026-08-26T02:17:41.695983Z","2026-05-05T02:43:27.675486Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT06982352","Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis",[45],"2026-08-26T02:16:13.426928Z","2026-05-05T02:35:31.599086Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":64,"content_modified":65},"NCT06857942","A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)",[20],"2026-08-26T02:15:31.806698Z","2026-05-05T02:43:27.092961Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":70,"content_modified":71},"NCT03816345","Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO",[45],"2026-08-26T02:16:10.529598Z","2026-05-05T02:43:26.680299Z",{"nct_id":73,"title":74,"phases":75,"status":13,"updated_at":76,"content_modified":77},"NCT07648602","PPD™ CorEvitas™ Psoriasis (PSO) Early Treatment Response Non-Interventional Study",[],"2026-08-26T02:18:46.948970Z","2026-06-16T05:54:07.903861Z",{"nct_id":79,"title":80,"phases":81,"status":13,"updated_at":82,"content_modified":83},"NCT07017699","A Study to Assess Deucravacitinib Safety in Pregnancy",[],"2026-08-26T02:17:05.172421Z","2026-05-13T02:55:06.606774Z",{"nct_id":85,"title":86,"phases":87,"status":13,"updated_at":88,"content_modified":89},"NCT03125655","Regulation of Inflammatory Genes in Psoriasis",[],"2026-08-26T02:17:49.709549Z","2026-05-13T02:55:06.108424Z",{"nct_id":91,"title":92,"phases":93,"status":13,"updated_at":94,"content_modified":95},"NCT04864886","Metabolic Profiling of Immune Responses in Immune-mediated Diseases",[],"2026-08-26T02:15:59.318403Z","2026-05-13T02:55:06.272434Z",{"nct_id":97,"title":98,"phases":99,"status":13,"updated_at":100,"content_modified":101},"NCT04170244","Skin Microbial Ecology in Atopic Dermatitis",[],"2026-08-26T02:18:11.042248Z","2026-05-13T02:55:06.242258Z",{"nct_id":103,"title":104,"phases":105,"status":13,"updated_at":106,"content_modified":107},"NCT02103361","Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project",[],"2026-08-26T02:15:23.202838Z","2026-05-13T02:55:06.081507Z",{"nct_id":109,"title":110,"phases":111,"status":13,"updated_at":112,"content_modified":113},"NCT05883371","IMPACT - AndHealth Autoimmune Research Registry",[],"2026-08-26T02:16:45.157238Z","2026-05-13T02:55:06.391385Z",{"nct_id":115,"title":116,"phases":117,"status":13,"updated_at":118,"content_modified":119},"NCT04751396","Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors",[],"2026-08-26T02:17:12.307088Z","2026-05-13T02:55:06.267732Z",{"nct_id":121,"title":122,"phases":123,"status":13,"updated_at":124,"content_modified":125},"NCT03932279","Characterization of the Microbiome in Cutaneous T Cell Lymphoma",[],"2026-08-26T02:18:02.701182Z","2026-05-13T02:55:06.180365Z",{"nct_id":127,"title":128,"phases":129,"status":13,"updated_at":130,"content_modified":131},"NCT00842283","Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target",[],"2026-08-26T02:17:17.791881Z","2026-05-13T02:55:06.064828Z",{"nct_id":133,"title":134,"phases":135,"status":13,"updated_at":136,"content_modified":137},"NCT07390487","The Effects of Audio-Based Therapy on Anxiety in Psoriasis",[],"2026-08-26T02:15:50.539717Z","2026-05-05T02:43:29.664998Z",{"nct_id":139,"title":140,"phases":141,"status":13,"updated_at":142,"content_modified":143},"NCT06574178","Use of Total-Body PET to Quantify Systemic and Cutaneous Inflammation in Psoriasis Patients Before and After Intervention With a Nutritionally Balanced Diet",[],"2026-08-26T02:16:22.235886Z","2026-05-05T02:43:28.503567Z",{"nct_id":145,"title":146,"phases":147,"status":13,"updated_at":148,"content_modified":149},"NCT07471048","A Study to Evaluate the Impact of a Magnolia Officinalis Dietary Supplement on Immune Biomarkers in Subjects With Psoriasis",[],"2026-08-26T02:15:22.311223Z","2026-05-05T02:43:27.755642Z",{"nct_id":151,"title":152,"phases":153,"status":13,"updated_at":154,"content_modified":155},"NCT05858632","Immune Spatial Features of Guselkumab Cutaneous Response",[20],"2026-08-26T02:17:21.315591Z","2026-05-05T02:43:27.492223Z",{"nct_id":157,"title":158,"phases":159,"status":160,"updated_at":161,"content_modified":162},"NCT07487831","The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease",[20],"NOT_YET_RECRUITING","2026-08-26T02:18:01.700186Z","2026-05-05T02:43:27.167487Z",{"nct_id":164,"title":165,"phases":166,"status":160,"updated_at":167,"content_modified":168},"NCT07654751","A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically",[20],"2026-08-26T02:19:08.862440Z","2026-06-17T19:21:16.688064Z",{"nct_id":170,"title":171,"phases":172,"status":160,"updated_at":173,"content_modified":174},"NCT07352566","Utilization of a Microdevice for Psoriasis and Atopic Dermatitis",[20],"2026-08-26T02:19:22.562392Z","2026-05-05T02:43:28.967159Z",{"nct_id":176,"title":177,"phases":178,"status":160,"updated_at":179,"content_modified":180},"NCT07391423","Assessing Psoriasis Treatment Outcomes",[],"2026-08-26T02:16:01.910993Z","2026-05-05T02:35:31.906552Z",{"nct_id":182,"title":183,"phases":184,"status":186,"updated_at":187,"content_modified":188},"NCT05981118","Comparison of Post-Inflammatory Pigment Alteration After Psoriasis Treatment (PIPA - Dermavant)",[185],"Phase 2\u002FPhase 3","ENROLLING_BY_INVITATION","2026-08-26T02:19:07.104270Z","2026-06-16T05:54:08.094290Z",{"nct_id":190,"title":191,"phases":192,"status":186,"updated_at":193,"content_modified":194},"NCT03254667","LTS of Siliq vs. Other Therapies Treating of Adults With Moderate-to-Severe Psoriasis",[],"2026-08-26T02:16:24.135291Z","2026-06-16T05:54:07.964610Z",{"nct_id":196,"title":197,"phases":198,"status":186,"updated_at":200,"content_modified":201},"NCT07050810","Thera-Clean® Microbubbles System in Patients With Skin Diseases",[199],"Early Phase 1","2026-08-26T02:16:32.589113Z","2026-06-16T05:54:07.850307Z",{"nct_id":203,"title":204,"phases":205,"status":186,"updated_at":206,"content_modified":207},"NCT06583395","Quest to Analyze One Thousand Humans Meditating",[],"2026-08-26T02:16:16.995720Z","2026-06-16T05:54:07.763563Z",{"nct_id":209,"title":210,"phases":211,"status":212,"updated_at":213,"content_modified":214},"NCT04110522","Psoriatic Arthritis D2P Screening",[],"ACTIVE_NOT_RECRUITING","2026-08-03T03:50:55.473026Z","2026-05-05T02:43:27.193920Z",{"nct_id":216,"title":217,"phases":218,"status":212,"updated_at":219,"content_modified":220},"NCT05621369","Psorcast Mobile Study",[],"2026-08-03T03:36:04.680662Z","2026-05-13T02:55:06.364720Z",{"nct_id":222,"title":223,"phases":224,"status":225,"updated_at":226,"content_modified":227},"NCT05635266","Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives",[],"UNKNOWN","2026-08-03T02:15:56.082035Z","2026-05-13T02:55:06.368062Z",[],[230,234,238,242,245,248,251,255,258,261,265,268,271],{"state":231,"count":232,"slug":233},"California",13,"california",{"state":235,"count":236,"slug":237},"New Jersey",7,"new-jersey",{"state":239,"count":240,"slug":241},"Massachusetts",5,"massachusetts",{"state":243,"count":240,"slug":244},"North Carolina","north-carolina",{"state":246,"count":240,"slug":247},"Ohio","ohio",{"state":249,"count":240,"slug":250},"Texas","texas",{"state":252,"count":253,"slug":254},"Illinois",4,"illinois",{"state":256,"count":253,"slug":257},"New York","new-york",{"state":259,"count":253,"slug":260},"Pennsylvania","pennsylvania",{"state":262,"count":263,"slug":264},"Florida",3,"florida",{"state":266,"count":263,"slug":267},"Georgia","georgia",{"state":269,"count":263,"slug":270},"Maryland","maryland",{"state":272,"count":263,"slug":273},"Utah","utah"]